Acorns Advisers LLC Grows Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Acorns Advisers LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 31.5% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 468 shares of the healthcare conglomerate’s stock after acquiring an additional 112 shares during the period. Acorns Advisers LLC’s holdings in UnitedHealth Group were worth $237,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Norges Bank purchased a new position in UnitedHealth Group in the fourth quarter worth $6,375,744,000. Raymond James Financial Inc. bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $1,914,740,000. Amundi boosted its stake in UnitedHealth Group by 97.2% in the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after buying an additional 2,991,470 shares in the last quarter. Proficio Capital Partners LLC raised its stake in shares of UnitedHealth Group by 76,830.4% during the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock worth $955,388,000 after acquiring an additional 1,886,186 shares in the last quarter. Finally, Franklin Resources Inc. boosted its stake in shares of UnitedHealth Group by 10.7% in the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock valued at $4,514,178,000 after purchasing an additional 861,854 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Down 0.6 %

Shares of NYSE:UNH opened at $583.43 on Wednesday. The stock’s 50-day simple moving average is $514.87 and its two-hundred day simple moving average is $542.12. UnitedHealth Group Incorporated has a 52-week low of $438.50 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $533.67 billion, a price-to-earnings ratio of 37.64, a PEG ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the company earned $5.83 earnings per share. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.44%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Wall Street Analyst Weigh In

UNH has been the subject of several analyst reports. Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Wells Fargo & Company decreased their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Mizuho raised their price target on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, April 9th. Finally, Truist Financial raised their target price on UnitedHealth Group from $610.00 to $660.00 and gave the stock a “buy” rating in a research note on Friday, April 11th. Twenty-one research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $632.85.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.